Innovative Collaboration Aims to Enhance Metastatic Colorectal Cancer Treatment Using LifeTracDx® Blood Test Creatv Bio partners with CytoDyn to utilize LifeTracDx® blood test for exploratory biomarker analysis in clinical trials for colorectal cancer treatment.

Innovative Collaboration Aims to Enhance Metastatic Colorectal Cancer Treatment Using LifeTracDx® Blood Test #USA #Creatv_Bio #Monmouth_Junction #CytoDyn #LifeTracDx

Innovative Blood Test Offers Hope for Treating Metastatic Triple-Negative Breast Cancer Creatv Bio's LifeTracDx blood test shows promise in monitoring PD-L1 upregulation for metastatic triple-negative breast cancer treatment options, improving survival rates.

Innovative Blood Test Offers Hope for Treating Metastatic Triple-Negative Breast Cancer #USA #Creatv_Bio #Monmouth_Junction #LifeTracDx #mTNBC

LifeTracDx® Blood Test Set to Revolutionize Colorectal Cancer Trials with CytoDyn The LifeTracDx® blood test is crucial in a new Phase II trial for colorectal cancer led by CytoDyn, enhancing treatment monitoring and diagnostics.

LifeTracDx® Blood Test Set to Revolutionize Colorectal Cancer Trials with CytoDyn #USA #Monmouth_Junction #Creatv_MicroTech #CytoDyn #LifeTracDx